Sonata Capital Group Inc. lifted its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report) by 197.4% during the fourth quarter, Holdings Channel reports. The fund owned 204,751 shares of the company’s stock after purchasing an additional 135,902 shares during the quarter. iShares iBonds Dec 2027 Term Corporate ETF comprises 2.0% of Sonata Capital Group Inc.’s portfolio, making the stock its 13th biggest holding. Sonata Capital Group Inc.’s holdings in iShares iBonds Dec 2027 Term Corporate ETF were worth $4,906,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Leavell Investment Management Inc. lifted its position in iShares iBonds Dec 2027 Term Corporate ETF by 34.2% during the fourth quarter. Leavell Investment Management Inc. now owns 163,717 shares of the company’s stock worth $3,923,000 after buying an additional 41,754 shares during the period. First Fiduciary Investment Counsel Inc. increased its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF by 24.3% during the 4th quarter. First Fiduciary Investment Counsel Inc. now owns 70,053 shares of the company’s stock valued at $1,678,000 after acquiring an additional 13,708 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of iShares iBonds Dec 2027 Term Corporate ETF during the 4th quarter worth about $158,000. Barrett & Company Inc. boosted its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 32.1% in the fourth quarter. Barrett & Company Inc. now owns 50,974 shares of the company’s stock worth $1,221,000 after acquiring an additional 12,389 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. grew its holdings in iShares iBonds Dec 2027 Term Corporate ETF by 68.4% in the fourth quarter. Migdal Insurance & Financial Holdings Ltd. now owns 16,855 shares of the company’s stock valued at $404,000 after purchasing an additional 6,844 shares during the period.
iShares iBonds Dec 2027 Term Corporate ETF Stock Down 0.0 %
Shares of IBDS stock opened at $23.99 on Wednesday. The company has a 50 day moving average price of $24.00 and a 200 day moving average price of $24.10. iShares iBonds Dec 2027 Term Corporate ETF has a one year low of $23.44 and a one year high of $24.68.
About iShares iBonds Dec 2027 Term Corporate ETF
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.
Featured Articles
- Five stocks we like better than iShares iBonds Dec 2027 Term Corporate ETF
- Manufacturing Stocks Investing
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- How to Read Stock Charts for Beginners
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- What Are Earnings Reports?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding IBDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report).
Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.